TradeTidings

You are viewing a historical snapshot of United Kingdom (London Stock Exchange). These figures are a preview to show what TradeTidings covers. Live, continuously updated United Kingdom sentiment and stock impact is a Pro feature.

Get live United Kingdom data with Pro
Medical Equipment & Services

Spire Healthcare (SPI)

0.00Neutral2 stories · last 90 days
Net news sentiment 0.00 (Neutral) across 2 stories · last 90 days. Not a price prediction.

2 stories published on SPI since July 2026. See all coverage.

News sentiment trend

Counts of positive, neutral, and negative news items over the last 90 days. Not a price chart.

Positive
0
Neutral
2
Negative
0

Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.

Sentiment timeline

How news sentiment on Spire Healthcare (SPI) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.

23 Jul

Why this reading

The recent items weighing most on this reading, by direction and influence.

Direct news

The most recent stories naming SPI directly, across all of our coverage.

Indirect drivers in the news

Macro, commodity, FX and regulatory forces that have moved SPI, with the stories behind each.

No indirect-driver news for SPI in our coverage yet.

Also monitored for SPI (no news in our coverage yet): Global growth / trade.

See the full picture

Sign up free to track SPI, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.

Track SPI for free

Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.